1. Home
  2. QURE vs LYTS Comparison

QURE vs LYTS Comparison

Compare QURE & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • LYTS
  • Stock Information
  • Founded
  • QURE 1998
  • LYTS 1976
  • Country
  • QURE Netherlands
  • LYTS United States
  • Employees
  • QURE N/A
  • LYTS N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • QURE Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • QURE Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • QURE 866.3M
  • LYTS 700.9M
  • IPO Year
  • QURE 2007
  • LYTS N/A
  • Fundamental
  • Price
  • QURE $64.16
  • LYTS $22.02
  • Analyst Decision
  • QURE Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • QURE 12
  • LYTS 2
  • Target Price
  • QURE $69.67
  • LYTS $27.50
  • AVG Volume (30 Days)
  • QURE 7.5M
  • LYTS 193.2K
  • Earning Date
  • QURE 11-04-2025
  • LYTS 11-06-2025
  • Dividend Yield
  • QURE N/A
  • LYTS 0.90%
  • EPS Growth
  • QURE N/A
  • LYTS N/A
  • EPS
  • QURE N/A
  • LYTS 0.79
  • Revenue
  • QURE $14,337,000.00
  • LYTS $573,377,000.00
  • Revenue This Year
  • QURE N/A
  • LYTS $5.91
  • Revenue Next Year
  • QURE $287.72
  • LYTS $8.03
  • P/E Ratio
  • QURE N/A
  • LYTS $27.99
  • Revenue Growth
  • QURE N/A
  • LYTS 22.09
  • 52 Week Low
  • QURE $5.23
  • LYTS $13.77
  • 52 Week High
  • QURE $65.12
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • QURE 83.29
  • LYTS 42.71
  • Support Level
  • QURE $50.80
  • LYTS $21.70
  • Resistance Level
  • QURE $57.57
  • LYTS $23.85
  • Average True Range (ATR)
  • QURE 5.17
  • LYTS 0.67
  • MACD
  • QURE 1.67
  • LYTS -0.32
  • Stochastic Oscillator
  • QURE 97.47
  • LYTS 10.39

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: